Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anca Vasculitis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anca Vasculitis Drugmarket, defines the market attractiveness level of Anca Vasculitis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anca Vasculitis Drug industry, describes the types of Anca Vasculitis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anca Vasculitis Drug market and the development prospects and opportunities of Anca Vasculitis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anca Vasculitis Drug market in Chapter 13.
By Player:
Kineta, Inc
ChemoCentryx, Inc
GlaxoSmithKline plc
By Type:
Belimumab
CCX-1378
CCX-168
Dalazatide
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anca Vasculitis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anca Vasculitis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anca Vasculitis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anca Vasculitis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anca Vasculitis Drug Market Analysis and Outlook to 2022
-
7.1 Global Anca Vasculitis Drug Consumption (2017-2022)
-
7.2 United States Anca Vasculitis Drug Consumption (2017-2022)
-
7.3 Europe Anca Vasculitis Drug Consumption (2017-2022)
-
7.4 China Anca Vasculitis Drug Consumption (2017-2022)
-
7.5 Japan Anca Vasculitis Drug Consumption (2017-2022)
-
7.6 India Anca Vasculitis Drug Consumption (2017-2022)
-
7.7 South Korea Anca Vasculitis Drug Consumption (2017-2022)
8 Region and Country-wise Anca Vasculitis Drug Market Analysis and Outlook to 2028
-
8.1 Global Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.2 United States Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.4 China Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.6 India Anca Vasculitis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Anca Vasculitis Drug Consumption Forecast (2022-2028)
9 Global Anca Vasculitis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Anca Vasculitis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Belimumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CCX-1378 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CCX-168 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Dalazatide Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anca Vasculitis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anca Vasculitis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Anca Vasculitis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CCX-1378 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Dalazatide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anca Vasculitis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anca Vasculitis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anca Vasculitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anca Vasculitis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anca Vasculitis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anca Vasculitis Drug Market Competitive Analysis
-
14.1 Kineta, Inc
-
14.1.1 Kineta, Inc Company Details
-
14.1.2 Kineta, Inc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Kineta, Inc Anca Vasculitis Drug Product and Service
-
14.2 ChemoCentryx, Inc
-
14.2.1 ChemoCentryx, Inc Company Details
-
14.2.2 ChemoCentryx, Inc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ChemoCentryx, Inc Anca Vasculitis Drug Product and Service
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Details
-
14.3.2 GlaxoSmithKline plc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline plc Anca Vasculitis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anca Vasculitis Drug
-
Figure Anca Vasculitis Drug Picture
-
Table Global Anca Vasculitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anca Vasculitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anca Vasculitis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anca Vasculitis Drug Consumption by Country (2017-2022)
-
Figure United States Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anca Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anca Vasculitis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anca Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Belimumab Consumption and Growth Rate (2017-2022)
-
Figure Global CCX-1378 Consumption and Growth Rate (2017-2022)
-
Figure Global CCX-168 Consumption and Growth Rate (2017-2022)
-
Figure Global Dalazatide Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CCX-1378 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dalazatide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anca Vasculitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anca Vasculitis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Kineta, Inc (Foundation Year, Company Profile and etc.)
-
Table Kineta, Inc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kineta, Inc Anca Vasculitis Drug Product and Service
-
Table ChemoCentryx, Inc (Foundation Year, Company Profile and etc.)
-
Table ChemoCentryx, Inc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ChemoCentryx, Inc Anca Vasculitis Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Anca Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Anca Vasculitis Drug Product and Service
-
